First- and Second-Generation Antipsychotics for Children and Young Adults
Adverse Effects: First-Generation Antipsychotics
There are few comparisons of first-generation antipsychotics (FGAs) with placebo that report differences in adverse events in children. The evidence is insufficient for all key adverse events.
FGAs versus FGAs:
The evidence is insufficient for all head-to-head comparisons of FGAs.
- Seida J, Schouten J, Mousavi S, et al. First- and Second-Generation Antipsychotics for Children and Young Adults. Comparative Effectiveness Review No. 39 (Prepared by the University of Alberta Evidence-based Practice Center under Contract No. 290-2007-10021). Rockville, MD: Agency for Healthcare Research and Quality; February 2012. AHRQ Publication No. 11(12)-EHC077-EF. Available at www.effectivehealthcare.ahrq.gov/pedantipsych.cfm.
Your slide tray is being processed.